STOCK BASED COMPENSATION (Tables)

9 Months Ended

Sep. 30, 2020

Share-based Payment Arrangement [Abstract]

Schedule of Nonvested Share Activity

A summary of the status of restricted stock awards as of September 30, 2020 and 2019 and the changes during the periods then ended is presented below:

	Three Months Ended September 30, 2020			Three Months Ended September 30, 2019
	Shares	Weighted- Average Fair Value at Grant Date		Shares	Weighted- Average Fair Value at Grant Date
Non-vested at beginning of the period	4,153,171	$	2.48	4,549,079	$	2.31
Granted	282,500	$	2.34	233,000	$	3.50
Forfeited	(74,586)	$	2.63	(213,875)	$	2.40
Vested	(204,816)	$	2.42	(215,026)	$	1.80
Non-vested at end of period	4,156,269	$	2.47	4,353,178	$	2.39

	Nine Months Ended September 30, 2020			Nine Months Ended September 30, 2019
	Shares	Weighted- Average Fair Value at Grant Date		Shares	Weighted- Average Fair Value at Grant Date
Non-vested at beginning of the period	3,994,787	$	2.46	4,518,932	$	2.32
Granted	2,143,000	$	2.68	2,100,790	$	2.65
Forfeited	(354,884)	$	2.85	(441,500)	$	2.75
Vested	(1,626,634)	$	2.64	(1,825,044)	$	2.43
Non-vested at end of period	4,156,269	$	2.47	4,353,178	$	2.39

A summary of the status of PSUs as of September 30, 2020 and 2019 and the changes during the periods then ended is presented below:

	Three Months Ended September 30, 2020			Three Months Ended September 30, 2019
	Shares	Weighted- Average Fair Value at Grant Date		Shares	Weighted- Average Fair Value at Grant Date
Non-vested at beginning of the period	1,587,607	$	2.50	1,722,500	$	2.48
Forfeited	(14,851)	$	2.55	(100,000)	$	2.35
Non-vested at end of period	1,572,756	$	2.41	1,622,500	$	2.49

	Nine Months Ended September 30, 2020			Nine Months Ended September 30, 2019
	Shares	Weighted- Average Fair Value at Grant Date		Shares	Weighted- Average Fair Value at Grant Date
Non-vested at beginning of the period	1,664,650	$	2.53	1,255,000	$	3.45
Granted	911,460	$	2.65	740,000	$	2.40
Forfeited	(680,778)	$	3.27	(372,500)	$	5.56
Vested	(322,576)	$	1.92	—	$	—
Non-vested at end of period	1,572,756	$	2.41	1,622,500	$	2.49

Weighted Average Remaining Contractual Life

A summary of the status of options previously granted as of September 30, 2020 and 2019, and the changes during the periods then ended, is presented below:

	Three Months Ended September 30, 2020
	Options	Weighted-Average Exercise Price		Aggregate Intrinsic Value
Options outstanding at beginning of the period	110,000	$	7.40	$	—
Options outstanding at end of period	110,000	$	7.40	$	—
Exercisable at end of period	110,000	$	7.40	$	—

	Three Months Ended September 30, 2019
	Options	Weighted-Average Exercise Price		Aggregate Intrinsic Value
Options outstanding at beginning of the period	193,000	$	8.28	$	—
Options outstanding at end of period	193,000	$	8.28	$	—
Exercisable at end of period	193,000	$	8.28	$	—

	Nine Months Ended September 30, 2020
	Options	Weighted-Average Exercise Price		Aggregate Intrinsic Value
Options outstanding at beginning of the period	190,000	$	8.28	$	—
Forfeited	(80,000)	$	9.48	$	—
Options outstanding at end of period	110,000	$	7.40	$	—
Exercisable at end of period	110,000	$	7.40	$	—

	Nine Months Ended September 30, 2019
	Options	Weighted-Average Exercise Price		Aggregate Intrinsic Value
Options outstanding at beginning of the period	327,000	$	8.35	$	—
Forfeited	(134,000)	$	8.46	$	—
Options outstanding at end of period	193,000	$	8.28	$	—
Exercisable at end of period	193,000	$	8.28	$	—

T

Schedule of Exercise Price Range

he following table summarizes information about options outstanding as of September 30, 2020:

Exercise Price	Options Outstanding and Exercisable	Weighted- Average Remaining Contractual Life
		(in years)
$  7.00 - $  7.99	100,000	0.4
$  8.00 - $  8.99	10,000	1.0
	110,000